These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 10565920

  • 21. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi.
    Liang FT, Alvarez AL, Gu Y, Nowling JM, Ramamoorthy R, Philipp MT.
    J Immunol; 1999 Nov 15; 163(10):5566-73. PubMed ID: 10553085
    [Abstract] [Full Text] [Related]

  • 22. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR, Oliver LD, Earnhart CG, Marconi RT.
    Vaccine; 2017 May 31; 35(24):3178-3185. PubMed ID: 28479174
    [Abstract] [Full Text] [Related]

  • 23. Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection.
    Zhang YQ, Mathiesen D, Kolbert CP, Anderson J, Schoen RT, Fikrig E, Persing DH.
    J Clin Microbiol; 1997 Jan 31; 35(1):233-8. PubMed ID: 8968914
    [Abstract] [Full Text] [Related]

  • 24. Effects of OspA vaccination on Lyme disease serologic testing.
    Aguero-Rosenfeld ME, Roberge J, Carbonaro CA, Nowakowski J, Nadelman RB, Wormser GP.
    J Clin Microbiol; 1999 Nov 31; 37(11):3718-21. PubMed ID: 10523583
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.
    Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD, Philipp MT, Steere AC, Wormser GP, Marques AR, Johnson BJ.
    J Infect Dis; 2003 Apr 15; 187(8):1187-99. PubMed ID: 12695997
    [Abstract] [Full Text] [Related]

  • 27. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S, Yang X, Huang X, Dunn JJ, Luft BJ.
    J Mol Biol; 2005 Jul 08; 350(2):290-9. PubMed ID: 15935380
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of the C6 enzyme-linked immunoadsorbent assay for the serodiagnosis of Lyme borreliosis in north-eastern Italy.
    Cinco M, Murgia R.
    New Microbiol; 2006 Apr 08; 29(2):139-41. PubMed ID: 16841555
    [Abstract] [Full Text] [Related]

  • 30. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.
    Jobe DA, Lovrich SD, Asp KE, Mathiason MA, Albrecht SE, Schell RF, Callister SM.
    Clin Vaccine Immunol; 2008 Jun 08; 15(6):981-5. PubMed ID: 18417666
    [Abstract] [Full Text] [Related]

  • 31. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.
    Aydintug MK, Gu Y, Philipp MT.
    Infect Immun; 1994 Nov 08; 62(11):4929-37. PubMed ID: 7927774
    [Abstract] [Full Text] [Related]

  • 32. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease.
    Kalish RA, Leong JM, Steere AC.
    Infect Immun; 1995 Jun 08; 63(6):2228-35. PubMed ID: 7768602
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis.
    Magnarelli LA, Fikrig E, Padula SJ, Anderson JF, Flavell RA.
    J Clin Microbiol; 1996 Feb 08; 34(2):237-40. PubMed ID: 8788993
    [Abstract] [Full Text] [Related]

  • 36. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B, Freer H, Rollins A, Erb HN, Lu Z, Gröhn Y.
    Vet Immunol Immunopathol; 2011 Dec 15; 144(3-4):374-81. PubMed ID: 21890217
    [Abstract] [Full Text] [Related]

  • 37. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.
    Ikushima M, Matsui K, Yamada F, Kawahashi S, Nishikawa SK.
    FEMS Immunol Med Microbiol; 2000 Sep 15; 29(1):15-21. PubMed ID: 10967255
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
    Wressnigg N, Barrett PN, Pöllabauer EM, O'Rourke M, Portsmouth D, Schwendinger MG, Crowe BA, Livey I, Dvorak T, Schmitt B, Zeitlinger M, Kollaritsch H, Esen M, Kremsner PG, Jelinek T, Aschoff R, Weisser R, Naudts IF, Aichinger G.
    Clin Vaccine Immunol; 2014 Nov 15; 21(11):1490-9. PubMed ID: 25185574
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.